Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by sah1on Jun 03, 2018 7:22am
211 Views
Post# 28116722

RE:RE:RE:RE:RE:RE:one egg is being rolled out to the launch pad

RE:RE:RE:RE:RE:RE:one egg is being rolled out to the launch pad RF, The deal will be structured along lines set out by Bruce Wendal as per his AGM presentation. Also I am hoping the numbers will be bigger than you are suggesting and more along the lines I laid out in my previous post. While no doubt a deal could have been struck 2 years ago, the terms would have been much less favourable. The reason Big Pharma is swarming over 4050 as we speak is because of not only favourable IPF trials but perhaps even more importantly the tremendous 52 week data from the Alstrom trials. And as you know the latter were only recently released. If negotiations go well perhaps we will see a Letter of Intent announced sometime next month. Fingers crossed:-)
Bullboard Posts